APA and PAS Training for Gait Initiation in Parkinson's Disease

April 9, 2024 updated by: Ya-Ju Chang, Chang Gung University

Gait-initiation Related APA Training in Individuals With Parkinson Disease -Explicit Training and Paired Associative Stimulation(PAS) Priming

Our research focused on understanding the interplay between brain excitability and balance function in patients with Parkinson's disease (PD), alongside evaluating effective physical therapy methods. It highlights the prevalence of non-motor disorders and cognitive impairments among PD patients, including balance and postural issues, cognitive function decline, and gait instability. Additionally, it notes that PD patients exhibit abnormal electrophysiological responses, indicating altered central excitability.

Study Overview

Detailed Description

Research on Brain Excitability and Balance Function Performance in Patients with Parkinson's Disease and Related Physical Therapy Methods

Research indicates that non-motor disorders and cognitive impairments are prevalent in most patients with Parkinson's disease. These include balance issues, postural instability, impaired cognitive functions like working memory and executive functions, and gait instability. Additionally, electrophysiological phenomena in Parkinson's disease patients reveal abnormal central excitatory and inhibitory responses compared to healthy individuals.

This experiment seeks to investigate the link between motor performance and brain excitability in patients with Parkinson's disease. Previous studies suggest that associative electrical stimulation, used to regulate sensorimotor information integration, can enhance brain excitability in both healthy individuals and those with Parkinson's disease. However, the optimal parameters for this stimulation remain uncertain.

Furthermore, balance exercise training can improve motor performance in Parkinson's disease patients. This study aims to determine if various designs of associative electrical stimulation parameters can help these patients achieve optimal brain excitability regulation. The combined approach of this stimulation and balance exercise training aims to maintain and improve the patients' functional performance, thereby enhancing the safety of their daily activities.

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Taoyuan, Taiwan, 333
        • Recruiting
        • Chang Gung University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Health subjects:

Exclusion Criteria:

  • Musculoskeletal injuries on legs.
  • Osteoporosis.

PD subjects:

Inclusion Criteria:

- Clinical diagnosis of Parkinson disease.

Exclusion Criteria:

  • Musculoskeletal injuries on legs
  • Osteoporosis.
  • Any peripheral or central nervous system injury or disease patients.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Stage 1:Healthy people
To establish PAS baseline and reliability.
Use TMS combine ES to stimulate TA nerve and M1 cortical
Other Names:
  • PAS group
Experimental: Stage 2:PD people
To establish stage 3 training protocol.
Use TMS combine ES to stimulate TA nerve and M1 cortical
Other Names:
  • PAS group
No Intervention: Stage 3:PD people
Control group.
Experimental: Stage 3: PD APA training group
Weight shift training and APA feedback.
Use COP trajectory to train weight shift on force plate. To give APA visual feedback for subjects after weight shift training.
Other Names:
  • • APA training group
Experimental: Stage 3:PD PAS group
Using PAS to regulate brain plasticity
Use TMS combine ES to stimulate TA nerve and M1 cortical
Other Names:
  • PAS group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Balance Performance
Time Frame: Baseline, 4 weeks and 8 weeks.
Measured by the duration the stance can be maintained. Unit:seconds(s)
Baseline, 4 weeks and 8 weeks.
COP Path Length in Balance Tasks
Time Frame: Baseline, 4 weeks and 8 weeks.
The total distance traveled by the COP over a specified period. Longer path lengths can indicate increased effort to maintain balance or greater instability. Unit:millimeters(mm)
Baseline, 4 weeks and 8 weeks.
COP Displacement in Balance Tasks
Time Frame: Baseline, 4 weeks and 8 weeks.
Measures of COP movement in the anterior-posterior (AP) and medial-lateral (ML) directions, offering insights into the directional tendencies of balance control. Unit:millimeters(mm)
Baseline, 4 weeks and 8 weeks.
Motor Evoked Potentials (MEPs)
Time Frame: Baseline, 4 weeks and 8 weeks.
MEPs are the electrical responses recorded from muscles following stimulation of the motor cortex. They reflect the efficiency of neural transmission from the cortex to the muscle. Unit:millivolts (mV)
Baseline, 4 weeks and 8 weeks.
Intracortical Facilitation (ICF)
Time Frame: Baseline, 4 weeks and 8 weeks.
ICF is measured by applying a pair of TMS pulses with a short interval (e.g., 8-15 ms) where the first (subthreshold) pulse is followed by a second (suprathreshold) pulse, leading to an increased amplitude of the MEP.
Baseline, 4 weeks and 8 weeks.
Intracortical Inhibition (ICI)
Time Frame: Baseline, 4 weeks and 8 weeks.
ICI is measured similarly to ICF but with a shorter inter-stimulus interval (e.g., 1-5 ms), resulting in a suppressed MEP amplitude. This suppression reflects inhibitory processes within the cortex.
Baseline, 4 weeks and 8 weeks.
Walking Speed
Time Frame: Baseline, 4 weeks and 8 weeks.
The time taken by participants to walk a standardized distance, typically expressed in centimeters per second (cm/s).
Baseline, 4 weeks and 8 weeks.
Step Length
Time Frame: Baseline, 4 weeks and 8 weeks.
The linear distance between the two ankles, typically expressed in centimeter(cm).
Baseline, 4 weeks and 8 weeks.
Step Time
Time Frame: Baseline, 4 weeks and 8 weeks.
The duration taken for one complete step, measuring from foot-off of one foot to the next foot-off of the same foot, usually expressed in seconds.
Baseline, 4 weeks and 8 weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
COP Velocity in Balance Tasks
Time Frame: Baseline, 4 weeks and 8 weeks.
The speed at which the COP moves, calculated over the duration of the balance task. Higher velocities may reflect more dynamic balance adjustments or instability. Unit:millimeters per second(mm/s)
Baseline, 4 weeks and 8 weeks.
COP Area in Balance Tasks
Time Frame: Baseline, 4 weeks and 8 weeks.
The area covered by the COP trajectory during the balance task, providing an estimate of the sway envelope. A larger area might indicate poorer balance control. Unit:square millimeters(mm^2)
Baseline, 4 weeks and 8 weeks.
Double Support Time
Time Frame: Baseline, 4 weeks and 8 weeks.
The portion of the gait cycle where both feet are in contact with the ground, indicating the transition phase between steps, expressed as a percentage of the gait cycle or in seconds.
Baseline, 4 weeks and 8 weeks.
Single Support Time
Time Frame: Baseline, 4 weeks and 8 weeks.
The duration within the gait cycle when only one foot is in contact with the ground, typically measured in seconds or as a percentage of the total gait cycle.
Baseline, 4 weeks and 8 weeks.
Swing Time
Time Frame: Baseline, 4 weeks and 8 weeks.
The portion of the gait cycle where the foot is not in contact with the ground, moving forward to the next step. It is usually expressed as a percentage of the total gait cycle or in seconds.
Baseline, 4 weeks and 8 weeks.
Stance Time
Time Frame: Baseline, 4 weeks and 8 weeks.
The portion of the gait cycle when the foot is in contact with the ground, supporting body weight. It's typically expressed as a percentage of the total gait cycle or in seconds
Baseline, 4 weeks and 8 weeks.
Cadence
Time Frame: Baseline, 4 weeks and 8 weeks.
The number of steps an individual takes per minute, providing an overview of gait speed and rhythm, , expressed as steps per minute.
Baseline, 4 weeks and 8 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 13, 2022

Primary Completion (Estimated)

March 31, 2025

Study Completion (Estimated)

May 31, 2025

Study Registration Dates

First Submitted

March 28, 2024

First Submitted That Met QC Criteria

April 9, 2024

First Posted (Actual)

April 12, 2024

Study Record Updates

Last Update Posted (Actual)

April 12, 2024

Last Update Submitted That Met QC Criteria

April 9, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on Weight shift training and APA feedback

Subscribe